CN114034804B - Method for measuring proline content in captopril tablet - Google Patents
Method for measuring proline content in captopril tablet Download PDFInfo
- Publication number
- CN114034804B CN114034804B CN202111282297.1A CN202111282297A CN114034804B CN 114034804 B CN114034804 B CN 114034804B CN 202111282297 A CN202111282297 A CN 202111282297A CN 114034804 B CN114034804 B CN 114034804B
- Authority
- CN
- China
- Prior art keywords
- solution
- captopril
- proline
- organic phase
- taking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention discloses a method for measuring proline content in captopril tablets. The invention has strong specificity and high sensitivity; the method has accurate and reliable detection result and can be used for quality control of the captopril tablet sample.
Description
Technical Field
The invention belongs to the field of chemical drug analysis and detection, and particularly relates to a detection method for determining proline in captopril tablets.
Background
Captopril is an angiotensin converting enzyme inhibitor and is often used in the treatment of hypertension and certain types of congestive heart failure. In the production of captopril, proline is often used as a raw material, or during production and storage, the content of proline is also monitored to ensure the quality of captopril.
Proline is an alpha-imino acid, can be regarded as a heterocyclic structure formed by substituting a hydrogen atom on self amino group by a side chain of the alpha-amino acid, and is one of common amino acids constituting proteins. The structural formula is as follows:
due to the fact that proline is low in captopril tablets, ultraviolet absorption of proline is poor, liquid chromatography detection cannot meet detection requirements, the common amino acid detection means is derivatization detection at present, operation is complex, interference exists, and reproducibility is poor.
Disclosure of Invention
The purpose of the invention is as follows: the invention aims to provide a method for determining proline in captopril tablets by adopting LC-MS (liquid chromatography-mass spectrometry).
The technical scheme is as follows:
an LC-MS analysis method for determining the proline content in captopril tablets is characterized by comprising the following steps: and determining the preparation of a sample solution of the captopril tablet, and accurately measuring the proline content in the captopril tablet by using a liquid phase-mass spectrometer and adopting an external standard method.
The method specifically comprises the following steps:
(1) Taking the captopril tablet, weighing, grinding, precisely weighing about 20mg (about equivalent to 5mg of captopril) of captopril tablet powder, putting the captopril tablet powder into a 10ml measuring flask, diluting with a blank solution, fixing the volume to a scale, shaking up, filtering, and taking a subsequent filtrate as a test solution.
(2) The captopril tablet sample solution was measured by LC-MS:
and (3) chromatographic column: waters xselectricity HSS T3,5 μm,4.6mm 250mm;
water phase: 0.05% aqueous formic acid; and (3) organic phase: acetonitrile
Column temperature: 30 ℃; flow rate: 1mL/min; sample introduction volume: 5 mu L of the solution;
an ion source: ESI; the scanning mode comprises the following steps: a SIM;
mass spectrum acquisition time: 0min to 5min;
collected ion (m/z): 116;
elution procedure:
| time (min) | 0 | 5 | 5.5 | 8.5 | 8.6 | 11 |
| Organic phase (%) | 0 | 0 | 90 | 90 | 0 | 0 |
(3) Accurately weighing a certain amount of proline to prepare a reference solution, injecting a sample, recording a chromatogram, and calculating the proline content in the captopril tablet by measuring the peak area and the concentration of the proline in the test solution according to an external standard method.
Has the beneficial effects that: (1) The invention develops a method for detecting the content of proline in the captopril by using a liquid phase-mass spectrometer, and simultaneously adopts an external standard method, so that the detection process is simple, and the detection result is accurate and reliable. The detection method has high response and strong specificity, and can be used for quality control of the captopril tablets; (2) The invention optimizes and selects LC-MS operation parameters in the detection process, has short detection time, and simultaneously ensures the specificity, accuracy and sensitivity of detection.
Drawings
FIG. 1 is a graph showing the results of detection of a sample by the method of the present invention in example 1.
Detailed Description
For the purpose of enhancing the understanding of the present invention, the present invention will be further described in detail with reference to the following examples and the accompanying drawings, which are only used for explaining the present invention and are not to be construed as limiting the scope of the present invention.
The following examples use the main instruments: LC-MS (model: thermo Vanqish UHPLC/Thermo TSQ QUANTIS, manufacturer: saimer Feishell science and technology (China) Co., ltd.); one in ten thousand electronic balance (model: XS205DU, manufacturer: mettler Toledo)
The control solutions used in the following examples were: proline (source: michelin; purity: 99%)
The solvents used in the following examples are: formic acid (source: TEDIA; purity: chromatographic grade), ultrapure water (Milli-Q), methanol (source: merck; purity: chromatographic grade), acetonitrile (source: merck; purity: chromatographic grade)
EXAMPLE 1 testing of captopril tablet samples from a manufacturer
(1) Preparation of captopril tablet samples:
respectively taking 5 captopril tablets of different batches of different manufacturers, weighing, grinding, precisely weighing an appropriate amount of captopril tablet powder (equivalent to 5mg of captopril), placing the captopril tablet powder into a 10ml measuring flask, diluting with a blank solution, fixing the volume to a scale, shaking up, filtering, and taking a subsequent filtrate as a sample solution. Two test solutions were prepared in parallel for each batch.
(2) Preparation of proline control solution:
blank solution: 50% methanol.
Control stock solutions: accurately weighing 5.378mg of proline reference substance, placing the proline reference substance in a 100ml measuring flask, dissolving the proline reference substance in a blank solution, fixing the volume to a scale, and shaking up to obtain a reference substance stock solution.
Standard limit control solution: precisely measuring 1ml of the reference substance stock solution, placing the reference substance stock solution in a 100ml measuring flask, diluting with a blank solution, fixing the volume to a scale, and shaking up to serve as a standard limit reference substance solution.
(3) The instrument method comprises the following steps:
liquid phase system: thermo Vanqish UHPLC
And (3) chromatographic column: waters XSelect HSS T3,5 μm,4.6mm 250mm
Column temperature: 30 deg.C
Sample injector temperature: 10 deg.C
Flow rate: 1ml/min
Sample introduction volume: 5 μ l
Water phase: 0.05% aqueous formic acid solution
Organic phase: acetonitrile
Elution conditions:
| time (min) | 0 | 5 | 5.5 | 8.5 | 8.6 | 11 |
| Organic phase (%) | 0 | 0 | 90 | 90 | 0 | 0 |
Operating time: 11min
Mass spectrometry: thermo TSQ QUANTIS Mass spectrometer
An ion source: ESI source
The scanning mode is as follows: SIM Positive ion mode
Mass to charge ratio (m/z): 116
Mass spectrum acquisition time: 0 to 5min
Ionization voltage: 3500V (+)
Sheath gas: 60Arb
Auxiliary gas: 15Arb
Tail blowing: 2Arb
Ion source temperature: 350 deg.C
Interface temperature: 350 deg.C
(4) And (3) analysis results:
the blank solution is not interfered at the retention time of the object to be detected; and (4) continuously injecting 6 needles of the standard limit reference substance solution, wherein the peak area RSD and the retention time RSD of the object to be detected both meet the requirements. Proline was not detected in all test samples.
Example 2 accuracy examination
(1) Preparing a solution:
blank solution: 50% methanol.
Control stock-1: accurately weighing 5.475mg of proline reference substance, placing the proline reference substance in a 100ml measuring flask, dissolving the proline reference substance by using a blank solution, fixing the volume to a scale, and shaking up to obtain reference substance stock solution-1.
Standard limit control solution: precisely measuring 1ml of reference substance stock solution, placing in a 100ml measuring flask, diluting with blank solution, metering to desired volume, and shaking to obtain reference substance solution as standard limit.
Test solution: weighing 20 captopril tablets, grinding, precisely weighing 20.26mg and 20.52mg (equivalent to 5.010mg and 5.075mg of captopril) of captopril tablet powder, respectively placing the captopril tablet powder and the captopril tablet powder into a 10ml measuring flask, diluting the captopril tablet powder with a blank solution, fixing the volume to the scale, shaking up, filtering, and taking a subsequent filtrate as two test solution.
Standard 50% limit add standard test solution: taking 20 captopril tablets, weighing, grinding, precisely weighing 20.05mg, 20.21mg and 20.60mg (equivalent to captopril 4.958mg, 4.998mg and 5.094 mg) of captopril tablet powder, respectively placing the captopril tablet powder, the captopril powder and the captopril powder in 10ml measuring bottles, diluting the captopril powder with 50% linear horizontal test solution under 4.4.1, fixing the volume to the scale, shaking up, filtering, and taking the subsequent filtrate as three parts of 50% standard limit standard sample solution.
Standard test solution addition at 100% standard limit: taking 20 captopril tablets, weighing, grinding, precisely weighing captopril tablet powder of 20.08mg, 20.26mg and 20.12mg (equivalent to captopril of 4.966mg, 5.010mg and 4.976 mg), respectively placing in a 10ml measuring flask, diluting with standard limit control solution, fixing the volume to scale, shaking up, filtering, and taking subsequent filtrate as three standard limit additive standard sample solutions.
Standard limit of 150% plus standard test article solution: taking 20 captopril tablets, weighing, grinding, precisely weighing 19.99mg, 20.55mg and 20.28mg (equivalent to captopril 4.944mg, 5.082mg and 5.015 mg) of captopril tablet powder, respectively placing the captopril tablet powder, the captopril powder and the 20.28mg in a 10ml measuring flask, diluting the captopril powder with 150% linear horizontal test solution under 4.4.1, fixing the volume to the scale, shaking up, filtering, and taking the subsequent filtrate as three 150% standard limit standard sample solutions.
(2) The instrument method comprises the following steps:
liquid phase system: thermo Vanqish UHPLC
And (3) chromatographic column: waters XSelect HSS T3,5 μm,4.6mm 250mm
Column temperature: 30 deg.C
Sample injector temperature: 10 deg.C
Flow rate: 1ml/min
Sample introduction volume: 5 μ l
Water phase: 0.05% aqueous formic acid solution
Organic phase: acetonitrile
Elution conditions:
| time (min) | 0 | 5 | 5.5 | 8.5 | 8.6 | 11 |
| Organic phase (%) | 0 | 0 | 90 | 90 | 0 | 0 |
Operating time: 11min
Mass spectrometry: thermo TSQ QUANTIS Mass spectrometer
An ion source: ESI source
The scanning mode is as follows: SIM Positive ion mode
Mass to charge ratio (m/z): 116
Mass spectrum acquisition time: 0 to 5min
Ionization voltage: 3500V (+)
Sheath gas: 60Arb
Auxiliary gas: 15Arb
Tail blowing: 2Arb
Ion source temperature: 350 deg.C
Interface temperature: 350 deg.C
(3) And (3) analysis results:
a sample is added into the sample solution of each of the three concentration levels, the recovery rate of each substance to be tested is 94.84-101.61%, the receiving standard (85-110%) of the accuracy parameter recovery rate is met, and the specific results are shown in the following table.
Example 3 repeatability test
(1) Preparing a solution:
blank solution: 50% methanol.
Control stock-1: accurately weighing 5.475mg of proline reference substance, placing in a 100ml measuring flask, dissolving with blank solution, fixing volume to scale, shaking up, and using as reference substance stock solution-1.
Standard limit control solution: precisely measuring 1ml of reference substance stock solution, placing in a 100ml measuring flask, diluting with blank solution, metering to desired volume, and shaking to obtain reference substance solution as standard limit.
Standard limit plus standard test solution: taking 20 captopril tablets, weighing, grinding, precisely weighing captopril tablet powder of 20.08mg, 20.26mg, 20.12mg, 20.52mg, 20.14mg and 19.95mg (equivalent to captopril of 4.966mg, 5.010mg, 4.976mg, 5.075mg, 4.981mg and 4.934 mg), respectively placing in a 10ml measuring flask, diluting with a standard limit control solution, fixing the volume to the scale, shaking uniformly, filtering, and taking the subsequent filtrate as six standard limit standard sample solutions.
(2) The instrument method comprises the following steps:
liquid phase system: thermo Vanqish UHPLC
A chromatographic column: waters XSelect HSS T3,5 μm,4.6mm 250mm
Column temperature: 30 deg.C
Sample injector temperature: 10 deg.C
Flow rate: 1ml/min
Sample introduction volume: 5 μ l
Water phase: 0.05% aqueous formic acid solution
Organic phase: acetonitrile
Elution conditions:
| time (min) | 0 | 5 | 5.5 | 8.5 | 8.6 | 11 |
| Organic phase (%) | 0 | 0 | 90 | 90 | 0 | 0 |
Operating time: 11min
Mass spectrometry: thermo TSQ QUANTIS mass spectrometer
An ion source: ESI source
The scanning mode is as follows: SIM Positive ion mode
Mass to charge ratio (m/z): 116
Mass spectrum acquisition time: 0 to 5min
Ionization voltage: 3500V (+)
Sheath gas: 60Arb
Auxiliary gas: 15Arb
Tail blowing: 2Arb
Ion source temperature: 350 deg.C
Interface temperature: 350 deg.C
(3) And (3) analysis results:
one injection is added into each of six standard limit sample solutions, the content of proline RSD is 1.16%, the receiving standard (less than or equal to 10%) of the repeatability parameter RSD is met, and the specific results are shown in the following table.
In conclusion, the method for detecting the proline in the captopril by the LC-MS is high in response and high in specificity; the method has accurate and reliable detection result and can be used for quality control of the captopril tablets.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (3)
1. The method for measuring the proline content in captopril tablets is characterized in that a liquid chromatography-mass spectrometer is used, an external standard method is adopted, and the accurate measurement of the proline content in captopril tablets is realized, wherein the detection conditions of the liquid chromatography-mass spectrometer are as follows:
(1) liquid chromatography conditions:
a chromatographic column: waters xslect HSS T3,5 μm,4.6mm 250mm;
mobile phase: water phase: 0.05% aqueous formic acid; organic phase: acetonitrile;
column temperature: 30 ℃; flow rate: 1mL/min; sample introduction volume: 5 mu L of the solution;
the water phase and the organic phase are mixed mobile phases for gradient elution, and the mobile phase gradient elution parameters are as follows: 0min,0% organic phase; 5min,0% organic phase; 5.5min,90% organic phase; 8.5min,90% organic phase; 8.6min,0% organic phase; 11min,0% organic phase;
(2) mass spectrum conditions: : in an electrospray ionization detection mode, a mass spectrum scanning mode of multi-reaction monitoring and a positive ionization mode are adopted, the ionization voltage is 3500V, and the ion source temperature is as follows: 350 ℃, sheath gas: 60Arb, assist gas: 15Arb, tail blowing: 2Arb, ion collection: m/z 116.
2. The method according to claim 1, characterized in that it comprises in particular the steps of:
1) Preparing a captopril tablet sample: taking captopril tablets, grinding, diluting with a blank solution, fixing the volume to a scale, shaking up, filtering, taking a subsequent filtrate, and preparing into a solution containing 0.5mg of captopril per 1 mL;
2) Preparing a reference solution: taking a proper amount of proline reference substance, and adding a blank solution to prepare a solution containing 500ng of proline per 1 mL;
3) And (3) sampling a test sample solution and a reference substance solution, recording a chromatogram, and calculating the content of proline in the captopril tablet by measuring the peak area and the concentration of proline in the test sample solution according to an external standard method.
3. The method as claimed in claim 2, wherein the blank solution in step 1) is a methanol aqueous solution with a mass fraction of 50%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111282297.1A CN114034804B (en) | 2021-11-01 | 2021-11-01 | Method for measuring proline content in captopril tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111282297.1A CN114034804B (en) | 2021-11-01 | 2021-11-01 | Method for measuring proline content in captopril tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114034804A CN114034804A (en) | 2022-02-11 |
| CN114034804B true CN114034804B (en) | 2023-04-18 |
Family
ID=80142441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111282297.1A Active CN114034804B (en) | 2021-11-01 | 2021-11-01 | Method for measuring proline content in captopril tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114034804B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8969089B2 (en) * | 2004-10-12 | 2015-03-03 | Quest Diagnostics Investments, Inc. | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
| CN101344509B (en) * | 2008-04-25 | 2011-05-25 | 广东中烟工业有限责任公司 | Mass spectrometry method for tobacco and its product amino acid |
| CN108426956B (en) * | 2018-04-13 | 2020-10-09 | 郑州泰丰制药有限公司 | Method for determining impurity F in captopril tablets by high performance liquid chromatography |
| CN109633030A (en) * | 2019-01-22 | 2019-04-16 | 江苏澳华生物科技研究院有限公司 | A kind of method that ultra performance liquid chromatography-QQ-TOF mass spectrometry detects amino acid in animal body fluid or tissue samples |
-
2021
- 2021-11-01 CN CN202111282297.1A patent/CN114034804B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114034804A (en) | 2022-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109212091A (en) | 25-hydroxy-vitamin D Liquid Chromatography-Tandem Mass Spectrometry combination detection method and kit in serum | |
| CN110031557B (en) | Method for detecting 5-isoquinoline methyl sulfonate and 5-isoquinoline ethyl sulfonate in fasudil hydrochloride | |
| CN113295805B (en) | Method for detecting hydrazine hydrate in medicine | |
| CN116773693A (en) | Method for detecting 11 antihypertensive drugs and 1 metabolite in blood by liquid chromatography-tandem mass spectrometry and application of method | |
| CN102980968A (en) | Liquid chromatogram tandem mass spectrum measuring method for creatinine in urine | |
| CN112730641B (en) | Ion chromatography determination method of N-methylpiperazine | |
| CN113804781A (en) | Detection and analysis method for hydrazine hydrate in dantrolene sodium | |
| CN106053695A (en) | Method for detecting content of ethyl carbamate in soybean-flavor Baijiu | |
| CN114034804B (en) | Method for measuring proline content in captopril tablet | |
| CN116953112A (en) | Analysis method for simultaneously determining sugar, organic acid, amino acid and Maillard reaction product in tobacco flavor | |
| CN111103384A (en) | Method for measuring concentration of endogenous homovanillic acid and vanillic mandelic acid in human urine by liquid chromatography-mass spectrometry | |
| CN114594174B (en) | Detection method of impurity A in indapamide preparation | |
| CN114047279A (en) | Method for measuring residual quantity of N-methylpiperazine in drug intermediate and bulk drug by high performance liquid chromatography-mass spectrometry | |
| CN114280191A (en) | Method for detecting related substances in bis-cysteine and preparation thereof | |
| CN109374778B (en) | Method for determining organic impurities in 2-mercaptobenzimidazole | |
| CN110231416B (en) | Method for measuring 2-iodoxybenzoic acid related substances by using HPLC (high performance liquid chromatography) | |
| CN111812253A (en) | Method for detecting potential genotoxic impurities in compound containing benzimidazole structure | |
| CN112903836A (en) | Method for determining isopropyl-beta-D-thiogalactopyranoside in-vitro cultured bear gall powder | |
| CN110749666A (en) | Liquid chromatography tandem mass spectrometry method for detecting busulfan in plasma | |
| CN116465990B (en) | Detection method for impurities of 1, 5-hexanediol, 1, 6-hexanediol and 3-methyl-1, 5-pentanediol in atracurium besylate and cis atracurium besylate bulk drug | |
| CN112461982A (en) | Detection method of L-camphorsulfonic acid methyl ester and L-camphorsulfonic acid ethyl ester | |
| CN109324139A (en) | Ribosylzeatin liquid-liquid extraction-liquid chromatography-tandem mass spectrometry measuring method in a kind of tobacco leaf | |
| CN112903856B (en) | Pretreatment method for detecting trace chloroformyl compound in water sample and application thereof | |
| CN114577943B (en) | Method for indirectly measuring aspartic acid and glutamic acid in infant formula milk powder and prepared milk powder | |
| CN117074578B (en) | LC-MS/MS quantitative detection method of 2- (methylamino) -ethanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |